Cited by 899Cancer-related Molecular PathwaysHeat shock proteins researchChromatin Remodeling and Cancer

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2

Open access

Kamijo, Takehiko, Weber, Jason D., Zambetti, Gerard, Zindy, Frederique, Roussel, Martine F., Sherr, Charles J.·1998·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.95.14.8292PMC PMC20969

Open this paper in CoChat — free account

Abstract

The INK4a-ARF locus encodes two proteins, p16(INK4a) and p19(ARF), that restrain cell growth by affecting the functions of the retinoblastoma protein and p53, respectively. Disruption of this locus by deletions or point mutations is a common event in human cancer, perhaps second only to the loss of p53. Using insect cells infected with baculovirus vectors and NIH 3T3 fibroblasts infected with ARF retrovirus, we determined that mouse p19(ARF) can interact directly with p53, as well as with the p53 regulator mdm2. ARF can bind p53-DNA complexes, and it depends upon functional p53 to transcriptionally induce mdm2 and the cyclin-dependent kinase inhibitor p21(Cip1), and to arrest cell proliferation. Binding of p19(ARF) to p53 requires the ARF N-terminal domain (amino acids 1-62) that is necessary and sufficient to induce cell cycle arrest. Overexpression of p19(ARF) in wild type or ARF-null mouse embryo fibroblasts increases the half-life of p53 from 15 to approximately 75 min, correlating with an increased p53-dependent transcriptional response and growth arrest. Surprisingly, when overexpressed at supra-physiologic levels after introduction into ARF-null NIH 3T3 cells or mouse embryo fibroblasts, the p53 protein is handicapped in inducing this checkpoint response. In this setting, reintroduction of p19(ARF) restores p53's ability to induce p21(Cip1) and mdm2, implying that, in addition to stabilizing p53, ARF modulates p53-dependent function through an additional mechanism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.95.14.8292

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,674
High-Efficiency Transformation of Mammalian Cells by Plasmid DNA
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,327
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Self-citation
QUANTITATIVE STUDIES OF THE GROWTH OF MOUSE EMBRYO CELLS IN CULTURE AND THEIR DEVELOPMENT INTO ESTABLISHED LINES
Todaro, G. J., & Green, H. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.2.299 · Cited by 2,747
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100

Flagged first, then by citations

Show all 61 references

Research works printed but not linked: 10

M Hollstein, K Rice, M S Greenblatt, T Soussi, R Fuchs, T Sorlie, E Hovig, B Smith-Sorensen, R Montesano, C C Harris Nucleic Acids Res 22, 3551–3555 (1994).
D Duro, O Bernard, V Della Valle, R Berger, C-J Larsen Oncogene 11, 21–29 (1995).
L Mao, A Merlo, G Bedi, G I Shapiro, C D Edwards, B J Rollins, D Sidransky Cancer Res 55, 2995–2997 (1995).
S Stone, P Jiang, P Dayananth, S V Tavtigian, H Katcher, D Parry, G Peters, A Kamb Cancer Res 55, 2988–2994 (1995).
10.1128/mcb.13.7.4107-4114.1993 · DOI
P W Hinds, C A Finlay, R S Quartin, S J Baker, E R Fearon, B Vogelstein, A J Levine Cell Growth Diff 1, 571–580 (1990).
10.1128/mcb.7.8.2745-2752.1987 · DOI
10.1126/science.256.5058.827 · DOI
10.1128/mcb.2.9.1044-1051.1982 · DOI
G Shaulsky, N Goldfinger, M S Tosky, A J Levine, V Rotter Oncogene 6, 2055–2065 (1991).

Sorted by citations

Items 601–700 of 896

Azacitidine induces demethylation of p16INK4a and inhibits growth in adult T-cell leukemia/lymphoma
Hatta, Y. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.756 · Cited by 17
INACTIVATION OF BOTH Rb AND p53 PATHWAYS IN MOUSE LUNG EPITHELIAL CELL LINES
McDoniels-Silvers, A. L., Herzog, C. R., Tyson, F. L., Malkinson, A. M., & You, M. (2001) · Experimental Lung Research · doi:10.1080/019021401300054064 · Cited by 17
The Acetylase Activity of p300 Is Dispensable for MDM2 Stabilization
Zeng, S. X., Jin, Y., Kuninger, D., Rotwein, P. S., & Lu, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209030200 · Cited by 17
A CRITICAL ANALYSIS OF THE USE OF p53 AS A MARKER FOR MANAGEMENT OF BLADDER CANCER
Olumi, A. F. (2000) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70236-6 · Cited by 17
Loss ofVHLpromotes progerin expression, leading to impaired p14/ARF function and suppression of p53 activity
Jung, Y., Lee, S.-J., Lee, S.-H., Chung, J.-Y., Jung, Y.-J., Hwang, S., Ha, N., & Park, B.-J. (2013) · Cell Cycle · doi:10.4161/cc.25371 · Cited by 16
p14ARF Post-Transcriptional Regulation of Nuclear Cyclin D1 in MCF-7 Breast Cancer Cells: Discrimination between a Good and Bad Prognosis?
McGowan, E. M., Tran, N., Alling, N., Yagoub, D., Sedger, L. M., & Martiniello‐Wilks, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042246 · Cited by 16
Polycomb complexes regulate cellular senescence by repression of ARF in cooperation with E2F3
Miki, J., Fujimura, Y., Koseki, H., & Kamijo, T. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01135.x · Cited by 16
Self-citation
Progressive silencing of p14ARF in oesophageal adenocarcinoma
Huang, Y., Peters, C. J., Fitzgerald, R. C., & Gjerset, R. A. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00336.x · Cited by 16
The ARF tumor-suppressor controls Drosha translation to prevent Ras-driven transformation
Kuchenreuther, M., & Weber, J. D. (2013) · Oncogene · doi:10.1038/onc.2012.601 · Cited by 16
Self-citation
Myeloma Overexpressed 2 (Myeov2) Regulates L11 Subnuclear Localization through Nedd8 Modification
Ebina, M., Tsuruta, F., Katoh, M., Kigoshi, Y., Akie, S., & Chiba, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065285 · Cited by 16
Independent genetic control of early and late stages of chemically induced skin tumors in a cross of a Japanese wild-derived inbred mouse strain, MSM/Ms
Okumura, K., Sato, M., Saito, M., Miura, I., Wakana, S., Mao, J., Miyasaka, Y., Kominami, R., & Wakabayashi, Y. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs250 · Cited by 16
p53 and p14 Increase Sensitivity of Gastric Cells to H. Pylori-Induced Apoptosis
Ashktorab, H., Ahmed, A., Littleton, G. K., Wang, X. W., Allen, C., Tackey, R., Walters, C. S., & Smoot, D. T. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1024198807619 · Cited by 16
p19ARF-induced p53-independent apoptosis largely occurs through BAX
Suzuki, H., Kurita, M., Mizumoto, K., Nishimoto, I., Ogata, E., & Matsuoka, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.071 · Cited by 16
Different p16INK4aand p14ARFExpression Patterns in Acute Myeloid Leukaemia and Normal Blood Leukocytes
Tschan, M. P., Vonlanthen, S., Cajot, J., Peters, U. R., Oppliger, E., Betticher, D. C., Yarbrough, W. G., Fey, M. F., & Tobler, A. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109097728 · Cited by 16
ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2
Chang, D. L. F., Qiu, W., Ying, H., Zhang, T., Chen, C. Y., & Xiao, Z.-X. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210254 · Cited by 16
Alterations in tumour suppressor gene p53 in human gliomas from Indian patients
Phatak, P., Selvi, S. K., Divya, T., Hegde, A. S., Hegde, S., & Somasundaram, K. (2002) · Journal of Biosciences · doi:10.1007/bf02708375 · Cited by 15
Multiple domains of the mouse p19ARF tumor suppressor are involved in p53-independent apoptosis
Matsuoka, M., Kurita, M., Sudo, H., Mizumoto, K., Nishimoto, I., & Ogata, E. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00080-9 · Cited by 15
A modified p53 overcomes mdm2-mediated oncogenic transformation: a potential cancer therapeutic agent.
Lin, J., Jin, X., Page, C., Sondak, V. K., Jiang, G., & Reynolds, R. K. (2000) · PubMed · Cited by 15
Aberrant promoter hypermethylation profile of cell cycle regulatory genes in malignant astrocytomas
Ohta, T., Watanabe, T., Katayama, Y., Yoshino, A., Yachi, K., Ogino, A., Komine, C., & Fukushima, T. (2006) · Oncology Reports · doi:10.3892/or.16.5.957 · Cited by 15
Canonical Signaling Pathways in Melanoma
Sun, L., & Arbesman, J. (2021) · Clinics in Plastic Surgery · doi:10.1016/j.cps.2021.05.002 · Cited by 14
Bivalent binding of p14ARF to MDM2 RING and acidic domains inhibits E3 ligase function
Kowalczyk, D., Nakasone, M. A., Smith, B. O., & Huang, D. T. C. (2022) · Life Science Alliance · doi:10.26508/lsa.202201472 · Cited by 15
Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor
Minges, J. T., Grossman, G., Zhang, P., Kafri, T., & Wilson, E. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.663641 · Cited by 15
ARF‐dependent regulation of ATM and p53 associated KZNF (Apak) protein activity in response to oncogenic stress
Wang, S., Tian, C., Xing, G., Gao, M., Jiao, W., Xiao, T., Yin, Y., He, F., & Zhang, L. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.08.015 · Cited by 14
p19Arf Represses Platelet-Derived Growth Factor Receptor β by Transcriptional and Posttranscriptional Mechanisms
Widau, R. C., Zheng, Y., Sung, C. Y., Zelivianskaia, A. S., Roach, L. E., Bachmeyer, K. M., Abramova, T. V., Desgardin, A., Rosner, A., Cunningham, J. M., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06424-11 · Cited by 15
Advances in malignant melanoma: genetic insights from mouse and man
Kabbarah, O. (2006) · Frontiers in bioscience · doi:10.2741/1849 · Cited by 14
siRNA‐mediated type 1 insulin‐like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53
Niu, J., Xu, Z., Li, X., & Han, Z. (2006) · Cell Biology International · doi:10.1016/j.cellbi.2006.09.021 · Cited by 14
Diosgenin inhibits the proliferation of gastric cancer cells via inducing mesoderm posterior 1 down-regulation-mediated alternative reading frame expression
Gu, L., Zheng, H., Zhao, R., Zhang, X., & Wang, Q. (2021) · Human & Experimental Toxicology · doi:10.1177/09603271211053292 · Cited by 13
MKK7 and ARF
Kotsinas, A., Papanagnou, P., Galanos, P., Schramek, D., Townsend, P. A., Penninger, J. M., Bártek, J., & Gorgoulis, V. G. (2014) · Cell Cycle · doi:10.4161/cc.28654 · Cited by 13
Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α
Kendig, R. D., Kai, F., Fry, E. A., & Inoue, K. (2017) · Cancer Investigation · doi:10.1080/07357907.2017.1303505 · Cited by 13
Analysis of Methylation Patterns and Expression Profiles of P14 Arf Gene in Patients with Oral Squamous Cell Carcinoma
Kordi-Tamandani, D. M., Moazeni‐Roodi, A., Ladez, M. A. R., Hashemi, M. M., Birjandian, E., & Torkamanzehi, A. (2010) · The International Journal of Biological Markers · doi:10.1177/172460081002500207 · Cited by 13
Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis
Dreidax, D., Gogolin, S., Schroeder, C., Muth, D., Brueckner, L. M., Hess, E. M., Zapatka, M., Theißen, J., Fischer, M., Ehemann, V., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt020 · Cited by 13
Suppression of Ras-mediated NIH3T3 transformation by p19ARF does not involve alterations of cell growth properties
Calabrò, V., Parisi, T., Cristofano, A. D., & Mantia, G. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202532 · Cited by 13
Caspase-dependent apoptosis by ectopic expression of E2F-4
Chang, Y., Nakajima, H., Illenye, S. A., Lee, Y., Honjo, N., Makiyama, T., Fujiwara, I., Mizuta, N., Sawai, K., Saida, K., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203833 · Cited by 13
B.A.C.
Acronyms (2012) · Legal Abbreviations and Acronyms · Cited by 13
p14ARF interacts with E2F factors to form p14ARF–E2F/partner‐DNA complexes repressing E2F‐dependent transcription
Zhang, H., Li, W., Gu, Y., Li, S., An, G., Ni, J., & Jia, H. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22446 · Cited by 12
MDM2 Implications for Potential Molecular Pathogenic Therapies of Soft-Tissue Tumors
Sun, S. Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113638 · Cited by 12
Novel MDM2 splice variants identified from oral squamous cell carcinoma
Sam, K. K., Gan, C. P., Yee, P. S., Chong, C., Lim, K. P., Karen‐Ng, L. P., Chang, W. S., Nathan, S., Rahman, Z. A. A., Ismail, S. M., et al. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.05.016 · Cited by 12
Cell-Cycle Regulation
Figel, S. A., & Fenstermaker, R. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812100-9.00018-8 · Cited by 12
Primary malignant lymphoma of the brain: Frequent abnormalities and inactivation of p14 tumor suppressor gene
Zhang, S., 遠藤, 純., Saito, T., Kouno, M., Kuroiwa, T., Washiyama, K., & Kumanishi, T. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00003.x · Cited by 12
The p53 Tumour Suppressor Protein
Hickman, E. S., & Helin, K. (2000) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2000.10647992 · Cited by 12
Selective requirement of H2B N-Terminal tail for p14ARF-induced chromatin silencing
Choi, J., Kim, H., Kim, K., Lee, B., Lu, W., & An, W. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr642 · Cited by 11
Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects of Arf tumor suppressor-deficient mice
van Oosterwijk, J. G., Li, C., Yang, X., Opferman, J. T., & Sherr, C. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707292114 · Cited by 11
Self-citation
Dynamics of p14ARF and Focal Adhesion Kinase-Mediated Autophagy in Cancer
Fontana, R., & Vivo, M. (2018) · Cancers · doi:10.3390/cancers10070221 · Cited by 12
Macrophage-mediated Bystander Effect Triggered by Tumor Cell Apoptosis
Huang, Y., Lee, C., Borgström, P., & Gjerset, R. A. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300080 · Cited by 11
p14ARF inhibits the growth of p53 deficient cells in a cell-specific manner
Li, Y., He, L., Bruce, A., Parihar, K., Ingram, A. J., Liu, L., & Tang, D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.04.011 · Cited by 11
Study on the Spatial Architecture of p53, MDM2, and p14ARF Containing Complexes
Савченко, А. Л., Yurchenko, M., Снопок, Б. А., & Kashuba, E. (2008) · Molecular Biotechnology · doi:10.1007/s12033-008-9116-x · Cited by 11
Molecular Biology of Malignant Melanoma
Pons, M., Mancheño‐Corvo, P., Martín‐Duque, P., & Quintanilla, M. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-77574-6_20 · Cited by 11
A role for cadherins in cellular signaling and differentiation
Knudsen, K. A., Frankowski, C., Johnson, K. R., & Wheelock, M. J. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1998)72:30/31+ · Cited by 88
Self-citation
Induction of p14ARF by E2F1 Contributes to 8-Chloro-Adenosine-Induced Apoptosis in Human Lung Cancer H1299 Cells
Li, W., Gu, Y., Zhang, H., Zhou, J., & Jia, H. (2009) · Chemotherapy · doi:10.1159/000230697 · Cited by 10
Distinct target genes and effector processes appear to be critical for p53-activated responses to acute DNA damage versus p53-mediated tumour suppression
Valent, L., & Strasser, A. (2013) · Biodiscovery · doi:10.7750/biodiscovery.2013.8.3 · Cited by 12
Molecular biology and genetic models of glioma and medulloblastoma
Lassman, A. B., & Holland, E. C. (2006) · CRC Press eBooks · doi:10.1201/b13439-70 · Cited by 10
Transfer of p14ARF gene in drug-resistant human breast cancer MCF-7/Adr cells inhibits proliferation and reduces doxorubicin resistance
Guo-chang, F. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00524-3 · Cited by 10
Suppression of E1A-Mediated Transformation by the p50E4F Transcription Factor
Fernandes, E. R., & Rooney, R. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4739 · Cited by 10
Integration of DNA damage and repair with murine double-minute 2 (Mdm2) in tumorigenesis
Lehman, J., & Mayo, L. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131216373 · Cited by 9
Do p53 stress responses impact organismal aging?
Hasty, P., Campisi, J., & Sharp, Z. D. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.12.02 · Cited by 9
Characterization of molecular pathways for targeting therapy in glioblastoma
Wagle, N. A., Nguyen, M., Carrillo, J., Truong, J., Dobrawa, L., & Kesari, S. (2020) · Chinese Clinical Oncology · doi:10.21037/cco-20-124 · Cited by 9
HDM2 impairs Noxa transcription and affects apoptotic cell death in a p53/p73-dependent manner in neuroblastoma
Shi, Y., Takenobu, H., Kurata, K., Yamaguchi, Y., Yanagisawa, R., Ohira, M., Koike, K., Nakagawara, A., Jiang, L., & Kamijo, T. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.05.026 · Cited by 9
Self-citation
Mutational analysis reveals a dual role of Mdm2 acidic domain in the regulation of p53 stability
Doleželová, P., Cetkovská, K., Vousden, K. H., & Uldrijan, S. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.05.034 · Cited by 9
Flow Cytometric Analysis of MDM2-Mediated Growth Arrest
Frum, R. A., & Deb, S. P. (2003) · Humana Press eBooks · doi:10.1385/1-59259-408-5:257 · Cited by 9
The LIM-Only Protein FHL2 Mediates Ras-Induced Transformation through Cyclin D1 and p53 Pathways
Labalette, C., Nouët, Y., Levillayer, F., Armengol, C., Renard, C.-A., Soubigou, G., Xia, T., Buendia, M., & Yu, W. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003761 · Cited by 9
Adenovirus Infection of Primary Malignant Lymphoid Cells
STRAIR, R. K., Sheay, W., Goodell, L. A., White, E., Rabson, A. B., & Medina, D. J. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190210187 · Cited by 9
Tumor Suppressor Gene Aberrations in Acute Myelogenous Leukemia
Stirewalt, D. L., & Radich, J. P. (2000) · Hematology · doi:10.1080/10245332.2000.11746484 · Cited by 9
p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression
Reinhardt, L. S., Groen, K., Xavier, A., & Avery‐Kiejda, K. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210078 · Cited by 8
Association of increased levels of TGF-β1 and p14ARF in prostate carcinoma cell lines overexpressing Egr-1
Parra, E., Gutiérrez, L. A. M., & Ferreira, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3472 · Cited by 8
Cyclin-Dependent Kinases and Their Regulators as Potential Targets for Anticancer Therapeutics
Bronchud, M. H., Brizuela, L., Gyuris, J., & Mansuri, M. M. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-664-5_11 · Cited by 8
LM23 is a novel member of the Speedy/Ringo family at the crossroads of life and death of spermatogenic cell
Cheng, Y., Liu, M., & Jia, M.-C. (2011) · Asian Journal of Andrology · doi:10.1038/aja.2011.21 · Cited by 8
The ink4a/arf Locus Evolution in Primates: Characterization of Three ARF Sequences
Tommaso, A. D., Soler, C., Roos, C., Kitzis, A., & Ladevèze, V. (2004) · DNA and Cell Biology · doi:10.1089/104454904322964760 · Cited by 8
A small nuclear RNA, hdm365, is the major processing product of the human mdm2 gene
Bartl, S. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg207 · Cited by 8
GLTSCR2 promotes the nucleoplasmic translocation and subsequent degradation of nucleolar ARF
Lee, S., Cho, Y.-E., Kim, S. H., Kim, Y. J., & Park, J. (2016) · Oncotarget · doi:10.18632/oncotarget.9957 · Cited by 8
Ultrasound Triggered Co‐Delivery of Therapeutic MicroRNAs and a Triple Suicide Gene Therapy Vector by Using Biocompatible Polymer Nanoparticles for Improved Cancer Therapy in Mouse Models
Sukumar, U. K., Wang, H., Telichko, A. V., Natarajan, A., Bettinger, T., Cherkaoui, S., Massoud, T. F., Dahl, J., & Paulmurugan, R. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000197 · Cited by 8
Pinning Control for the p53-Mdm2 Network Dynamics Regulated by p14ARF
Suárez, O. J., Vega, C. J., Sanchez, E. N., Santiago, A. E. G., Rodríguez-Jorge, O., Alanís, A. Y., Chen, G., & Hernandez-Vargas, E. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00976 · Cited by 9
P53 and other Cell Cycle Regulators
Farid, N. R. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-8107-3_8 · Cited by 8
The INK4A/Arf Network — Cell Cycle Checkpoint or Emergency Brake?
del Arroyo, A. G., & Peters, G. G. (2005) · Advances in experimental medicine and biology · doi:10.1007/1-4020-3764-3_8 · Cited by 8
Gatekeepers of the Guardian: p53 Regulation by Post-Translational Modification, MDM2 and MDMX
Wahl, G. M., Stommel, J. M., Krummel, K. A., & Wade, M. R. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_4 · Cited by 9
Three molecular determinants of malignant conversion and their potential as therapeutic targets
Dome, J. S., & Look, A. T. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199901000-00013 · Cited by 8
The role of the C' terminus of murine p53 in the p53/mdm-2 regulatory loop
Almog, N. (2001) · Carcinogenesis · doi:10.1093/carcin/22.5.779 · Cited by 7
Genome-scale transcriptional analysis reveals key genes associated with the development of type II diabetes in mice
Zhang, Y., Han, D., Yu, P., Huang, Q., & Ge, P. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4042 · Cited by 8
Control of the Cell Cycle
Malumbres, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00004-9 · Cited by 10
Mechanisms of Asbestos-Induced Carcinogenesis
Toyokuni, S., Jiang, L., Hu, Q., Nagai, H., Okazaki, Y., Akatsuka, S., & Yamashita, Y. (2011) · Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene) · doi:10.1265/jjh.66.562 · Cited by 8
The Japanese Wild-Derived Inbred Mouse Strain, MSM/Ms in Cancer Research
Okumura, K., Saito, M., Isogai, E., & Wakabayashi, Y. (2021) · Cancers · doi:10.3390/cancers13051026 · Cited by 7
To clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · Inside the Cell · doi:10.1002/icl3.1046 · Cited by 8
HDM2 overexpression and focal loss of p14/ARF expression may deregulate the p53 tumour suppressor pathway in meningeal haemangiopericytomas. Study by double immunofluorescence and laser scanning confocal microscopy
Martínez, J., Palomino, J., Cabello, A., Sepúlveda-Sánchez, J. M., de la Cámara, A. G., & Ricoy, J. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02074.x · Cited by 7
Phospho-SIM and exon8b of PML protein regulate formation of doxorubicin-induced rDNA-PML compartment
Hornofova, T., Pokorna, B., Hubáčková, S., Uvizl, A., Kosla, J., Bártek, J., Hodný, Z., & Vašicová, P. (2022) · DNA repair · doi:10.1016/j.dnarep.2022.103319 · Cited by 5
New Insights into Melanoma Tumor Syndromes
Rashid, S., Gupta, S., McCormick, S. R., & Tsao, H. (2022) · JID Innovations · doi:10.1016/j.xjidi.2022.100152 · Cited by 6
Regulation of the Cell Cycle and Interventional Developmental Therapeutics
Ivanchuk, S. M., & Rutka, J. T. (2006) · Elsevier eBooks · doi:10.1016/b978-012088410-0/50047-0 · Cited by 6
Update and developments in the treatment of glioblastoma multiforme – focus on bevacizumab
Cloughesy, T. F., & Wagle (2010) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s7940 · Cited by 6
Analysis of p53 Tumor Suppressor Pathway Genes in Chronic Lymphocytic Leukemia
Işın, M., Yenerel, M. N., Aktan, M., Buyru, N., & Dalay, N. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1314 · Cited by 6
Elucidation of functional consequences of signalling pathway interactions
Ihekwaba, A., Nguyen, P. T., & Priami, C. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-370 · Cited by 6
Molecular Pathology of Glioblastoma- An Update
Santosh, V., Palavalasa, S., & Arivazhagan, A. (2017) · Current cancer research · doi:10.1007/978-3-319-56820-1_2 · Cited by 5
p53 N-terminal binding and stabilisation by PIAS3 inhibits MDM2-induced p53 ubiquitination and regulates cell growth
Zhao, Z., Wu, L., Shi, H., & Wu, C. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.1993 · Cited by 6
Current advances in the inhibition of the auto-regulatory interaction between the p53 tumour suppressor protein and MDM2 protein
Dart, D. A., Mansoor, M. S., Loadman, P. M., & Picksley, S. M. (2001) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.11.12.1825 · Cited by 6
Imminent approaches towards molecular interventions in ageing
Wadhwa, R., Deocaris, C. C., Widodo, N., Taira, K., & Kaul, S. C. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.10.004 · Cited by 6
Central Nervous System Tumors
Lassman, A. B., & Holland, E. C. (2004) · Wiley eBooks · doi:10.1002/0471675067.mmc012 · Cited by 6
Turning p53 on or off: either way may treat cancer
Fisher, D. E. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0128 · Cited by 6
Lymphoid Malignancies
Teitell, M. A., & Pandolfi, P. P. (2004) · Wiley eBooks · doi:10.1002/0471675067.mmc014 · Cited by 6
Rodent models of tumours of the central nervous system
Brandner, S. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13729 · Cited by 5
Bmi1 – A Path to Targeting Cancer Stem Cells
Bakhshinyan, D., Adile, A., Venugopal, C., & Singh, S. K. (2017) · European Oncology & Haematology · doi:10.17925/eoh.2017.13.02.147 · Cited by 5
Mouse p10, an Alternative Spliced Form of p15INK4b, Inhibits Cell Cycle Progression and Malignant Transformation
de Castro, I. P., Benet, M., Jiménez, M., Alzabin, S., Malumbres, M., & Pellicer, À. (2005) · Cancer Research · doi:10.1158/0008-5472.can-03-3445 · Cited by 5
ARF-mediated SUMOylation of Apak antagonizes ubiquitylation and promotes its nucleolar accumulation to inhibit 47S pre-rRNA synthesis
Wang, S., Wang, S., Yang, L., Guo, H., Kong, X., Yuan, L., Xing, G., He, F., & Zhang, L. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv010 · Cited by 5
A Polymorphic Variant in p19Arf Confers Resistance to Chemically Induced Skin Tumors by Activating the p53 Pathway
Saito, M., Okumura, K., Isogai, E., Araki, K., Tanikawa, C., Matsuda, K., Kamijo, T., Kominami, R., & Wakabayashi, Y. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.12.027 · Cited by 5
Self-citation

Authors: Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., & Sherr, C. J.
Affiliations: St. Jude Children's Research Hospital (US)
Howard Hughes Medical Institute and Departments of Tumor Cell Biology and Biochemistry, St. Jude Children’s Research Hospital, 332 North Lauderdale, Memphis, TN 38105
Corresponding author: Sherr, Charles J.
ORCID: Kamijo, Takehiko
Weber, Jason D.
Zambetti, Gerard
Roussel, Martine F.
Sherr, Charles J.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 1998-07-07
Volume: 95
Issue: 14
Pages: 8292-8297
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.95.14.8292
PMC: PMC20969
OpenAlex: W2141529421
Cited by: 899
References: 61
Citations by year: 2026: 5 · 2025: 5 · 2024: 2 · 2023: 10 · 2022: 11 · 2021: 15 · 2020: 10 · 2019: 10 · 2018: 12 · 2017: 14 · 2016: 26 · 2015: 21 · 2014: 33 · 2013: 28 · 2012: 34
FWCI: 31.09
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: St. Jude Children's Research Hospital (CA21765)
American Lebanese Syrian Associated Charities (CA 21765)
National Institutes of Health (CA21765))
National Cancer Institute (R01CA063230, CA-71907, CA-63230, CA21765, P30CA021765, P01CA071907)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: p19ARF, p53, MDM2, INK4a/ARF locus, p16INK4a, protein-protein interaction, p53 stabilization, p21 Cip1, cell cycle arrest, p53-dependent transcription, tumor suppressor, p53 DNA binding, N-terminal domain
MeSH terms: Animals, Humans, Neoplasm Proteins, Nuclear Proteins, Proteins, Proto-Oncogene Proteins, Retroviridae, Transfection, Gene Expression Regulation, Neoplastic, Genes, Tumor Suppressor, Tumor Suppressor Protein p53, 3T3 Cells, Tumor Suppressor Protein p14ARF, Mice, Proto-Oncogene Proteins c-mdm2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks